Prevalence and predictors of metabolic syndrome in schizophrenia patients from Assam.

Background: Metabolic abnormalities contribute enormously to morbidity and mortality in schizophrenia.

Objectives: Our objectives were to determine the (i) prevalence of metabolic syndrome (MS); and (ii) predictors for MS in schizophrenia patients from Assam.

Materials And Methods: Seventy-five schizophrenia patients were evaluated for MS.